Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Performance Development Group | Contract Pharma

What are you searching for?

Sign in

Search by

Performance Development Group

Company Headquarters

5 Great Valley Parkway, Suite 210, Malvern, PA, 19355, US

Driving Directions Phone: View Phone
View website

Request more information from Performance Development Group

Request more information from Performance Development Group

Categories from Performance Development Group

Consulting
Consulting, Talent
Contract Sales Organizations
Lead Optimization
Recruiting/Hiring
Training

Related Content

Collaborations & Alliances

Ori Biotech Lands 10-Year, $120M Commercial Cell Therapy Manufacturing Deal

The strategic collaboration was agreed upon with an undisclosed biopharmaceutical company.

By: Patrick Lavery

Breaking News

Evonik Breaks Ground on New Biotechnology Expansion Project in Slovakia

The project is slated for completion in 2028 and will create approximately 50 new jobs.

By: Patrick Lavery

Collaborations & Alliances

Matica Bio, Bondwell Partner on Texas Biotech

Collaboration aims to support manufacturing readiness for next-generation bioprocessing technologies.

By: Charlie Sternberg

Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius

The 3,500-square-meter BIO CITY III facility adds up to 20 cGMP manufacturing lines for cell therapies and personalized medicine.

By: Tim Wright

Promotions & Moves

Symbiosis Appoints Jay Chima as VP, Business Development

Chima brings more than 16 years of commercial experience across pharma, biotech and CDMO markets.

By: Charlie Sternberg

Promotions & Moves

AN2 Therapeutics Names Dr. Cameron Trenor as Chief Medical Officer

Trenor is a physician-scientist and biotechnology executive with 20+ years of experience leading clinical and translational development programs.

By: Charlie Sternberg

Breaking News

Halo Pharma to Activate Sterile Injectable Line in NJ

The $45 million investment expands domestic sterile manufacturing capacity for pharma and biotech clients.

By: Charlie Sternberg

Promotions & Moves

FUJIFILM Biotechnologies Transitions Leadership

Maja Pedersen has been appointed President to drive next phase of operational growth.

By: Kristin Brooks

Promotions & Moves

Vir Biotechnology Appoints Brent Sabatini as Interim Principal Financial Officer

The company has initiated a search to identify its next Chief Financial Officer.

By: Charlie Sternberg

Promotions & Moves

Kalaris Therapeutics Appoints Liisa Bayko as New CFO

Bayko brings more than two decades of experience in biotechnology finance, strategy, and capital markets.

By: Patrick Lavery

Promotions & Moves

Elevara Medicines Appoints Dr. Mai-Britt Zocca as CEO

Zocca offers extensive operational and strategic experience in the international biotechnology sector.

By: Charlie Sternberg

Promotions & Moves

Illuminare Biotechnologies Names Brian Longstreet as CEO

Longstreet offers 30 years of pharmaceutical, biotechnology and medical technology experience.

By: Charlie Sternberg

Promotions & Moves

Mikart Names Darrin T. Schellin as CEO

Schellin brings 20+ years of executive leadership experience across the pharmaceutical, biotechnology, and CDMO sectors.

By: Charlie Sternberg

Online Exclusives

Inside Pharma’s Push for More Resilient Supply Chains

Industry leaders from Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing, dual sourcing and networked CDMO capacity are reshaping pharma supply chains.

By: Charlie Sternberg

Breaking News

Parexel Launches Parexel Biotech Incubator 

Initiative creates new resource to support and accelerate early-stage therapeutics companies.

By: Kristin Brooks